Results 241 to 250 of about 623,427 (284)
Some of the next articles are maybe not open access.

Influence of beta glucosidases from native yeast on the aroma of Muscat and Tannat wines

Food Chemistry, 2021
BEATRIZ M Brena, Paula González-Pombo
exaly  

alpha-Glucosidase in Pompe's disease.

Journal of inherited metabolic disease, 1980
Isoelectric precipitation at pH 5.0 and the use of the inhibitors, turanose, maltose and citrate, enabled the diagnosis of Pompe's disease to be made in dextran-isolated leucocytes using 4-methylumbelliferyl-alpha-D-glucopyranoside as substrate. These techniques were unnecessary with lymphocytes as the deficiency of acid alpha-glucosidase could be ...
D M, Broadhead, J, Butterworth
openaire   +1 more source

alpha-Glucosidase inhibition in obesity.

Acta medica Scandinavica. Supplementum, 1986
Acarbose is an alpha-glucosidase inhibitor which reversibly and competitively inhibits the digestion of oligo- and disaccharides at the brush border of the small intestine. This study evaluates the preventive and therapeutic properties of acarbose in the treatment of obesity. Dose-response experiments were performed during repeated sucrose loads in man
openaire   +1 more source

[Specificity of fungal alpha-glucosidases].

Biokhimiia (Moscow, Russia), 1977
Studies of substrate and cosubstrate specificities of mould alpha-glucosidases suggest that the binding site of the active center of mould alpha-glucosidase consits of two subsites--glucone and aglucone ones. The glucone site is capable to bind glucose and mannose, whereas the aglucone one- some compounds whose affinity for the enzyme may be expressed ...
openaire   +1 more source

alpha-glucosidase (CHO) (Genzyme).

Current opinion in investigational drugs (London, England : 2000), 2005
Genzyme General is developing recombinant human alpha-glucosidase, produced in mammalian cell culture, as a potential treatment for Pompe disease. By July 2004, enrollment was completed in two clinical trials and an observational study in adults. Genzyme was planning to file for regulatory approval in Europe during 2004, followed by filings in the US ...
openaire   +1 more source

Pharmacology of alpha-glucosidase inhibition.

European journal of clinical investigation, 1995
The development of alpha-amylase and brush-border alpha-glucosidase inhibitors is reviewed. The mode of action as well as pharmacological and pharmacodynamic properties of selected inhibitors with special regard to the most thoroughly investigated alpha-glucosidase inhibitor acarbose are discussed. Inhibition of intestinal alpha-glucosidases delays the
openaire   +1 more source

Les inhibiteurs des alpha-glucosidases

Actualites Pharmaceutiques, 2017
Sébastien Fauré
exaly  

[Alpha-Glucosidase inhibitors].

Nihon rinsho. Japanese journal of clinical medicine, 2011
Yukio, Horikawa, Jun, Takeda
openaire   +1 more source

Home - About - Disclaimer - Privacy